Board Certified Neurosurgeon Joins DHR Health Neuroscience Institute  

Translate to Spanish or other 102 languages!

Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source:  googlemaps
Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source: googlemaps

Mega Doctor News

- Advertisement -

Edinburg, TX – The DHR Health Neuroscience Institute is pleased to welcome Inad B. Atassi, M.D, F.A.C.S., to the team. Utilizing the most advanced surgical techniques to provide comprehensive neurological care to patients, Dr. Atassi specializes in the treatment of brain tumors, spinal cord tumors, stroke and traumatic head & spine injuries.

Dr. Atassi is Board Certified in Neurosurgery and brings more than 35 years of experience in the field to patients of the Rio Grande Valley. He received his Doctor of Medicine at Damascus University in Damascus, Syria. He completed his General Surgery residency at Henry Ford Hospital in Detroit, Michigan and continued his Neurosurgery residency training at the University of Kansas Medical Center in Kansas City, Kansas.

Dr. Atassi has been in private practice, as well as worked in clinics and hospitals around the world providing neurologic care to adult and pediatric patients before bringing his talents to South Texas in 2020.He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, American College of Surgeons, North Carolina Medical Society, Cumberland County Medical Society, and North American Spine Society.

- Advertisement -

To schedule an appointment with Dr. Atassi, please call (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

Scientists Reverse Brain Aging With a Nasal Spray

Picture this: your brain is a high-performance engine. Over decades, it doesn’t just wear down; it also starts to run hot.
- Advertisement -